Primary Cns Lymphoma

[Maryther-Oropeza-MD]

This article has been medically reviewed by Marither Oropeza, MD — 2022-7-22

Who are the top experts researching treatments for primary cns lymphoma?

The top experts researching primary cns lymphoma are: Joshua Lukenbill, Christopher Dittus and Elsa Pennese.

What are the top concepts researched in studies about primary cns lymphoma?

The most researched concepts in studies of primary cns lymphoma are: Central Nervous, Cerebrospinal Fluid, Breast Cancer, Newly Diagnosed, Radiation Therapy, Phase Iii, Solid Tumors, Tumor Cells, Long Term and Advisory Committees.

What are some of the top places that specialize in primary cns lymphoma?

Recommended institutions that specialize in primary cns lymphoma:

NYU Langone Hematology / Oncology Brooklyn 902 Quentin Rd 7th floor, Brooklyn, NY 11223 Phone: +19177369740

South Orange Cty Hem/onc Assocs 24953 Paseo De Valencia # 25B, Laguna Hills, CA 92653 Phone: +19497708168

International Journal of Research and Reports in Hematology Third Floor, 207 Regent St., London W1B 3HH, United Kingdom Phone: +918617752708

Herr Prof. Dr. med. Kai Uwe Chow Schaubstraße 16, 60596 Frankfurt am Main, Germany Phone: +4969968642210

Primary Cns Lymphoma

[Maryther-Oropeza-MD]

This article has been medically reviewed by Marither Oropeza, MD — 2022-7-22

#1	Lisa Marie DeAngelis
Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY. | Memorial Sloan Kettering Cancer Center, Department of Neurology, 1275 York Avenue New York, ... Central Nervous | Brain Metastases | Primary Cns Lymphoma | Leptomeningeal Metastasis | Recurrent Glioblastoma

#2	Lauren Eileen Abrey
Novartis, Basel, Switzerland. | Memorial Sloan Kettering Cancer Center, New York, NY, USA | Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York ... Recurrent Glioblastoma | Central Nervous | Primary Cns Lymphoma | Brain Metastases | Rano Criteria

#3	Joachim Yahalom
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States. | Memorial Sloan-Kettering Cancer Center, New York, New York, United States ... Radiation Therapy | Hodgkin Lymphoma | Breast Cancer | Brentuximab Vedotin | Primary Refractory

#4	Andrés J M Ferreri
Lymphoma Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. | Lymphoma Unit, Department of Onco-hematology, ... Cell Lymphoma | Diffuse Large | Central Nervous | Marginal Zone | Consolidation Radiotherapy

#5	Michele Reni
Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Pancreas Translational and Clinical Research Centre, Milan, Italy | Pancreas Translational & Clinical ... Pancreatic Cancer | Maintenance Olaparib | Primary Cns Lymphoma | Lung Metastasis | Consolidation Radiotherapy

#6	Ulrich Herrlinger
Centre of Integrated Oncology (CIO), University Hospital Bonn, D-53127 Bonn, Germany | Division of Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, ... Glioblastoma Patients | Primary Cns Lymphoma | Brain Radiotherapy | Central Nervous | Recurrent Malignant Glioma

#7	Michael Weller
Department of Neurology, University Hospital Zurich, 8091 Zurich, Switzerland | Department of Neurology, Clinical Neuroscience Center University Hospital and University of ... Glioma Cells | Multiple Sclerosis | Newly Diagnosed Glioblastoma | Cell Death | Elderly Patients

#8	Tracy T Batchelor
Department of Neurology, Brigham and Women's Hospital, Boston, MA. | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and. | Department of Neurology, ... Recurrent Glioblastoma | Brain Metastases | Antiangiogenic Therapy | Primary Cns Lymphoma | Central Nervous

#9	Eckhard Thiel
Department of Hematology and Oncology, Charité Berlin, University of Berlin, Hindenburgdamm 30, D-12203 Berlin, Germany;, korfel_agnieszka@lilly.com, (A.K.);, ... Bone Marrow | Cell Lines | Primary Cns Lymphoma | Lymphoblastic Leukemia | Central Nervous

#10	Brian Patrick O'Neill
Mayo Clinic, Rochester, MN | Mayo Clinic, Rochester, Minnesota. | IU Health University Hospital, Indianapolis, Indiana, USA | Mayo Clinic, Rochester, MN; | Department of ... Central Nervous | Primary Cns Lymphoma | Mayo Clinic | Stereotactic Radiosurgery | Neurological Complications

#11	Franco Cavalli
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. | Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland | Istituto Oncologico della ... Cell Lymphoma | Breast Cancer | European School | Marginal Zone | Multiple Myeloma

#12	Emanuele Zucca
Department of Oncology, IOSI—Oncology Institute of Southern Switzerland, Bellinzona; Università della Svizzera Italiana, Bellinzona, Switzerland | Oncology Institute of ... Cell Lymphoma | Marginal Zone | Diffuse Large | Multiple Myeloma | Subcutaneous Rituximab

#13	Fred H Hochberg
Massachusetts General Hospital, Boston, Massachusetts, USA | Scintillon Institute, La Jolla, CA, United States. | University of California, San Diego, Department of ... Extracellular Vesicles | Brain Tumors | Primary Cns Lymphoma | Central Nervous | Malignant Glioma

#14	Agnieszka Korfel
Department of Hematology and Oncology, Charité Berlin, University of Berlin, Hindenburgdamm 30, D-12203 Berlin, Germany;, korfel_agnieszka@lilly.com, (A.K.);, ... Primary Cns Lymphoma | Central Nervous | Meningeal Dissemination | Brain Radiotherapy | Cns Relapse

#15	Edward A Neuwelt
Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA | Department of Neurological Surgery, Oregon Health & Science University, Portland, Oregon, ... Brain Barrier | Central Nervous | Sodium Thiosulfate | Osmotic Blood | Intraarterial Chemotherapy

#16	Khê Hoang‐Xuan
Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service ... Intensive Chemotherapy | Central Nervous | Primary Cns Lymphoma | Elderly Patients | Oligodendroglial Tumors

#17	Maurilio Ponzoni
Pathology Unit, IRCCS San Raffaele Hospital, Milan, Italy. | Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy | Strategic Research ... Cell Lymphoma | Bone Marrow | Diffuse Large | Marginal Zone | Multiple Myeloma

#18	Martina Deckert
Institute. of Neuropathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany | Institute of Neuropathology, Faculty of Medicine ... Central Nervous | Primary Cns Lymphoma | Toxoplasma Encephalitis | Malignant Progression | Autoimmune Neuritis

#19	Carole Soussain
Hematology, Institut Curie, Site Saint‐Cloud, INSERM U932, PSL Research University, Paris, France | Institut Curie, saint-cloud, France. | Service d'Hématologie, Institut ... Intensive Chemotherapy | Primary Cns Lymphoma | Central Nervous | Loc Network | Cns Relapse

#20	Uwe S Schlegel
Department of Neurology, University Hospital Knappschaftskrankenhaus, Ruhr–Universität Bochum, Bochum, Germany | Department of Neurology, University Hospital ... Primary Cns Lymphoma | Central Nervous | Syllable Repetition | Vowel Articulation | Methionine Metabolism

[Maryther-Oropeza-MD]

This article has been medically reviewed by Marither Oropeza, MD — 2022-7-22

Glucocorticoid Treatment Of Primary Cns Lymphoma

.. with primary CNS lymphoma. Since glucocorticoids will obscure the histological diagnosis of primary CNS lymphoma upon biopsy, steroids should be withheld if primary CNS lymphoma is a ...

Primary Cns Lymphoma | Glucocorticoid Therapy | Immunocompromised Patients | Histological Diagnosis | Lymphoid Cells

Diagnostic Accuracy Of T1-Weighted Dynamic Contrast-Enhanced–mri And Dwi-Adc For...

.. and primary CNS lymphoma dictate different neurosurgical strategies; it is critical to distinguish them preoperatively. However, current imaging modalities do not effectively differentiate ...

Primary Cns Lymphoma | Dynamic Contrast | Perfusion Imaging | Enhancing Component | Histogram Analysis

Rituximab In Patients With Primary Cns Lymphoma (Hovon 105/allg Nhl 24): A...

.. for primary CNS lymphoma has improved with the use of high-dose methotrexate-based chemotherapy, but patient outcomes remain poor. Rituximab, a chimeric monoclonal antibody that targets ...

Primary Cns Lymphoma | Rituximab Patients | Complete Response | Dose Methotrexate | Based Chemotherapy

Diagnosis And Treatment Of Primary Cns Lymphoma In Immunocompetent Patients:...

.. of primary CNS lymphoma is one of the most controversial topics in neuro-oncology because of the complexity of the disease and the very few controlled studies available. In 2013, the ...

Primary Cns Lymphoma | Immunocompetent Patients | Neuro Oncology | Intensive Chemotherapy | Cell Transplantation

Hemorrhage And Vegf Expression In A Case Of Primary Cns Lymphoma

.. in primary CNS lymphoma is exceedingly rare. We describe a patient with primary CNS lymphoma who presented with seizures and was found to have an intracerebral hemorrhage which prompted a ...

Primary Cns Lymphoma | Vegf Expression | Endothelial Growth | Intracerebral Hemorrhage | Factor Vascular

Methotrexate And Temozolomide Versus Methotrexate, Procarbazine, Vincristine, And...

.. for primary CNS lymphoma, reflecting an absence of randomised studies. We prospectively tested two promising methotrexate-based regimens, one more intensive and a milder regimen, for ...

Primary Cns Lymphoma | Elderly Population | Methotrexate Procarbazine | 95 Patients | Vincristine Aged

Cognitive Status And Quality Of Life After Treatment For Primary Cns Lymphoma

.. for primary CNS lymphoma (PCNSL). All patients were in complete remission after combined modality treatment with IV and intrathecal high-dose methotrexate (MTX)-based chemotherapy followed ...

Primary Cns Lymphoma | Patients Pcnsl | Quality Life | Cognitive Impairment | Cortical Atrophy

Gene Expression And Angiotropism In Primary Cns Lymphoma

Primary CNS lymphoma is an aggressive form of non-Hodgkin lymphoma whose growth is restricted to the central nervous system. We used cDNA microarray analysis to compare the gene expression ...

Cns Lymphoma | Gene Expression | Tumor Cells | Large Bcell | Activated Form

Neuropsychological Outcome After Chemotherapy For Primary Cns Lymphoma

.. for primary CNS lymphoma (PCNSL) is associated with a considerable risk of long-term neurotoxicity. The impact of high-dose methotrexate (MTX)-based chemotherapy alone on cognition and ...

Primary Cns Lymphoma | Patients Pcnsl | Mtxbased Chemotherapy | Longterm Followup | Complete Remission

Primary Cns Lymphoma With Intraocular Involvement

.. with primary CNS lymphoma (PCNSL) with ocular involvement.

METHODS: A retrospective study of 221 patients was assembled from 16 centers in seven countries. Only HIV-negative, ...

Intraocular Involvement | Primary Cns Lymphoma | Brain Eyes | Csf Cytology | Retrospective Studies

Meningeal Dissemination In Primary Cns Lymphoma

.. in primary CNS lymphoma (PCNSL) is debated, and the reported frequency varies. We prospectively evaluated the diagnostic value of PCR in comparison with CSF cytomorphology and MRI for ...

Meningeal Dissemination | Primary Cns Lymphoma | Csf Cytomorphology | Cranial Mri | Immunoglobulin Heavy

Case Report Of Unusual Leukoencephalopathy Preceding Primary Cns Lymphoma

.. with primary CNS lymphoma and died 14 months later. The unusual clinical course preceding the diagnosis suggests that a demyelinating disease may have preceded, and possibly heralded, the ...

Primary Cns Lymphoma | Multiple Sclerosis | Demyelinating Disease | Sentinel Lesions | Unusual Clinical

Current Uses Of Radiation Therapy In Patients With Primary Cns Lymphoma

.. for primary CNS lymphoma. Whole-brain radiotherapy (WBRT) plays an important role in the management of primary CNS lymphoma and is indicated in patients with contraindication to ...

Primary Cns Lymphoma | Radiation Therapy | Complete Remission | Highdose Methotrexate | Central Nervous

Primary Cns Lymphoma

Primary CNS lymphoma, an uncommon form of extranodal non-Hodgkin's lymphoma, has increased in incidence and occurs in both immunocompromised and immunocompetent hosts. Primary CNS lymphoma in ...

Primary Cns | Immunocompetent Patients | Radiation Therapy | Highly Active | Risk Neurotoxicity

Primary Cns Lymphoma.

Primary CNS lymphoma (PCNSL), an uncommon form of extranodal non-Hodgkin's lymphoma (NHL), has increased in incidence during the last three decades and occurs in both immunocompromised and ...

Primary Cns Lymphoma | Neurotoxicity Patients | Tumor Response Rates | Stereotactic Biopsy | Diagnostic Evaluation

Whole-Brain Radiotherapy Or Autologous Stem-Cell Transplantation As Consolidation...

.. diagnosed primary CNS lymphoma. Results of the first randomisation have demonstrated that methotrexate, cytarabine, thiotepa, and rituximab (called the MATRix regimen) is the induction ...

Wbrt Asct | Primary Cns Lymphoma | Autologous Stem | Cell Transplantation | Dose Methotrexate

Therapy Of Primary Cns Lymphoma With Methotrexate-Based Chemotherapy And Deferred...

.. in primary CNS lymphoma has improved with the advent of methotrexate-based pre-irradiation chemotherapy. Prolonged response durations have been noted in six of eight patients refusing ...

Primary Cns Lymphoma | Deferred Radiotherapy | Based Chemotherapy | Doxorubicin Female Humans | Patients Radiation Therapy

High-Dose Methotrexate For Elderly Patients With Primary Cns Lymphoma.

.. with primary CNS lymphoma (PCNSL). Older age is a negative prognostic marker in patients with PCNSL and may increase the likelihood of MTX toxicity. We studied the response and adverse ...

Elderly Patients | Primary Cns Lymphoma | Dose Methotrexate | 70 Years | Pcnsl Age

Primary Cns Lymphoma In The Elderly: Temozolomide Therapy And Mgmt Status

.. with primary CNS lymphoma (PCNSL) and severe comorbidities. In 17 patients (62–90 years old), the complete response rate was 47%, median progression-free survival was 5 months, and median ...

Primary Cns Lymphoma | Mgmt Status | Antineoplastic Agents | Elderly Patients | Cns Pcnsl

Treatment-Induced Leukoencephalopathy In Primary Cns Lymphoma

.. of primary CNS lymphoma (PCNSL). Its mechanism is poorly understood and there are no autopsy data available on such patients.

METHODS: From a database of immunocompetent patients with ...

Primary Cns Lymphoma | Induced Leukoencephalopathy | White Matter | Patients Pcnsl | Brain Neoplasms